Standout Papers
- Ranibizumab for Diabetic Macular Edema (2012)
- Ranibizumab for Macular Edema following Central Retinal Vein Occlusion (2010)
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration (2019)
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study (2011)
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema (2012)
- Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion (2014)
- Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders (2021)
- Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study (2024)
Immediate Impact
2 by Nobel laureates 11 from Science/Nature 91 standout
Citing Papers
Age-Related Macular Degeneration
2024 Standout
Age-related macular degeneration
2023 Standout
Works of David M. Brown being referenced
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
2019 Standout
A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David M. Brown | 8409 | 6331 | 1305 | 2439 | 289 | 14.9k | |
| David M. Brown | 12855 | 10112 | 1714 | 3667 | 159 | 22.2k | |
| Jeong Hun Kim | 2418 | 1606 | 1023 | 4190 | 409 | 10.8k | |
| Akira Hirata | 1634 | 1400 | 661 | 2914 | 360 | 9.2k | |
| Wei Li | 971 | 2699 | 317 | 3041 | 401 | 10.5k | |
| Xueguang Zhang | 635 | 1105 | 281 | 2130 | 382 | 10.1k | |
| Hiroaki Ozaki | 1539 | 938 | 295 | 2891 | 233 | 6.2k | |
| Peizeng Yang | 5017 | 412 | 111 | 1969 | 401 | 8.4k | |
| J. E. Scott | 371 | 969 | 229 | 4936 | 274 | 15.4k | |
| Ke Yang | 592 | 502 | 2011 | 1549 | 336 | 7.9k | |
| Wen Li | 552 | 323 | 1143 | 5793 | 451 | 11.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...